Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,021 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A

NCT03245021

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Ballarat Health Ballarat, Victoria, Australia
  • Eastern Health Box Hill, Victoria, Australia
  • Monash Health Clayton, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Active, Not Recruiting

A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

NCT05878691

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Froedtert & Medical College of Wisconsin - Froedtert Hospital - Clinical Cancer Center Milwaukee, Wisconsin, United States
  • Hcg City Cancer Centre Vijayawada, Andhra Pradesh, India
  • Mahatma Gandhi Cancer Hospital and Research Institute Visakhapatnam, Andhra Pradesh, India
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)

NCT05879744

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions